Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab-Reference-Cited by-同舟云学术

Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab

Published:2005 Issue:8 Volume:52 Page:2519-2520
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Anelli Maria Grazia,Torres Diletta Domenica,Manno Carlo,Scioscia Crescenzio,Iannone Florenzo,Covelli Michele,Schena Francesco Paolo,Lapadula Giovanni

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference8 articles.

1. AMYLOIDOSIS: A REVIEW OF RECENT DIAGNOSTIC AND THERAPEUTIC DEVELOPMENTS

2. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

3. Anti-tumor necrosis factor ? therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy

4. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

5. FDA. Safety update on TNF-α antagonists: infliximab and etanercept. FDA, Center for Biologics Evaluation and Research; 2001. URL: http://www.fda.gov/ohrms/dockets/ac/01/ briefing/3779b2.htm.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal involvement in pediatric inflammatory bowel disease;Česko-slovenská pediatrie;2023-12-11

2. Complete remission of nephrotic syndrome secondary to amyloid a amyloidosis in patient with inactive Crohn's disease after treatment by infliximab;Saudi Journal of Kidney Diseases and Transplantation;2018

3. Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review;Clinical Rheumatology;2013-12-11

4. Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a clinical setting;British Journal of Dermatology;2013-02-28

5. Use of biological disease-modifying anti-rheumatic drugs in patients with concurrent rheumatic disease and hepatitis B;Internal Medicine Journal;2012-05